AstraZeneca Covid-19 Vaccine | Page 2 | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
February 03, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, FEBRUARY 03, 2023

AstraZeneca Covid-19 Vaccine

Photo: Courtesy
Bangladesh

Bangladesh to get over 6.34 lakh doses of AstraZeneca from Japan Aug 28

Photo: Courtesy
Covid-19 in Bangladesh

7.81 lakh doses of AstraZeneca arrive from Japan

2nd consignment of AstraZeneca vaccines arrive from Japan 
Covid-19 in Bangladesh

2nd consignment of AstraZeneca vaccines arrive from Japan 

AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. Picture taken March 16, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

AstraZeneca exploring options for Covid-19 vaccine business, exec says

A medical worker prepares a dose of Oxford/AstraZeneca's COVID-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman
Coronavirus chronicle

AstraZeneca Covid-19 vaccine shipped to Canada, Mexico before adequate plant inspections

A medical worker prepares a dose of Oxford/AstraZeneca's COVID-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman
Coronavirus chronicle

AstraZeneca finds small clot risk after 1st Covid shot, less after 2nd

Vials with Pfizer-BioNTech and AstraZeneca coronavirus disease (Covid-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer, Astrazeneca vaccine antibody levels may decline in 2-3 months: Lancet study

Vials with Pfizer-BioNTech and AstraZeneca coronavirus disease (Covid-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Mixed AstraZeneca-Pfizer shot boosts Covid antibody level - study

Representational image. Photo: Courtesy
Covid-19 in Bangladesh

Japan to send 2.9M doses of AstraZeneca vaccine to Bangladesh: Ito Naoki

Vials of Johnson & Johnson's Janssen coronavirus disease (COVID-19) vaccine candidate are seen in an undated photograph. Johnson & Johnson/Handout via REUTERS.
Coronavirus chronicle

J&J, AstraZeneca explore Covid-19 vaccine modification after blood clot reports

Vials with AstraZeneca's coronavirus disease (Covid-19) vaccine are seen at the vaccination centre in the Newcastle Eagles Community Arena, in Newcastle upon Tyne, Britain, January 30, 2021. REUTERS/Lee Smith
Coronavirus chronicle

Countries using Astrazeneca shots eye boosters to cope with Delta variant

Vials with AstraZeneca's coronavirus disease (Covid-19) vaccine are seen at the vaccination centre in the Newcastle Eagles Community Arena, in Newcastle upon Tyne, Britain, January 30, 2021. REUTERS/Lee Smith
Coronavirus chronicle

Oxford vaccine produces strong immune response from booster shot - study

AstraZeneca produces antibodies in 93% recipients after 2nd dose: Study
Covid-19 in Bangladesh

AstraZeneca produces antibodies in 93% recipients after 2nd dose: Study

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net